Compare JAZZ & RPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAZZ | RPM |
|---|---|---|
| Founded | 2003 | 1947 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paints/Coatings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 13.2B |
| IPO Year | 2007 | 1994 |
| Metric | JAZZ | RPM |
|---|---|---|
| Price | $248.75 | $106.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $217.57 | $126.54 |
| AVG Volume (30 Days) | ★ 789.8K | 712.9K |
| Earning Date | 05-05-2026 | 04-08-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | N/A | ★ 17.32 |
| EPS | ★ 4.43 | 3.43 |
| Revenue | $1,618,693,000.00 | ★ $5,321,643,000.00 |
| Revenue This Year | $6.22 | $6.91 |
| Revenue Next Year | $7.68 | $5.15 |
| P/E Ratio | $54.80 | ★ $30.91 |
| Revenue Growth | N/A | ★ 7.33 |
| 52 Week Low | $105.00 | $92.92 |
| 52 Week High | $250.49 | $129.12 |
| Indicator | JAZZ | RPM |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 51.03 |
| Support Level | $222.49 | $104.29 |
| Resistance Level | $250.49 | $108.33 |
| Average True Range (ATR) | 7.32 | 2.49 |
| MACD | 0.01 | -0.52 |
| Stochastic Oscillator | 89.13 | 46.41 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
RPM International Inc manufactures and sells a variety of paints, coatings, and adhesives. The firm organizes itself into four segments based on product type. The construction products group sells coatings, roofing, insulation, and other products to distributors, contractors, and end consumers globally. The performance coatings group produces coatings that are used in construction and industrial applications like floorings and corrosion control. The consumer group sells paint, finishes, and similar products to individual consumers through hardware and craft stores. The specialty products group sells a line of products ranging from niche applications of the other groups to marine finishes, to edible food colorings. The majority of revenue is from the construction products and North America.